In conclusion, we developed a prognostic model for HCC via risk score and our data showed that POLQ displayed as a biomarker connected to HCC progression and associated with CIN which enables guide clinical diagnosis, prognosis, and therapeutic. The gene discussed is POLQ; the disease is hepatocellular carcinoma.